BIM
AZN icon

Bogle Investment Management’s AstraZeneca AZN Stock Holding History

Bogle Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-45,573
Closed -$4.82M – 233
2020
Q2 		$4.82M Buy
+45,573
New +$4.71M 0.8% 15
2020
Q1 		– Sell
-26,085
Closed -$2.6M – 278
2019
Q4 		$2.6M Sell
26,085
-37,315
-59% -$3.51M 0.24% 123
2019
Q3 		$5.65M Buy
+63,400
New +$5.5M 0.49% 79

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bogle Investment Management's AZN Position: Q3 2020 in Review

Bogle Investment Management sold out of AstraZeneca (AZN) in Q3 2020, closing a stake of 45,573 shares — an estimated $4.82M sold.

Bogle Investment Management first reported a position in AZN in Q3 2019 and held it in 3 quarters. The position peaked at $5.65M in Q3 2019. 722 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Bogle Investment Management reported no remaining AstraZeneca position as of Q3 2020 after selling out during the quarter.
  • Bogle Investment Management sold 45,573 AstraZeneca shares in Q3 2020, an estimated $4.82M.
  • Bogle Investment Management first reported a position in AstraZeneca in Q3 2019 and held it in 3 quarters.
  • Bogle Investment Management's AstraZeneca position peaked at $5.65M in Q3 2019.
  • 722 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Bogle Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.